A new approach to protein drug delivery.

Traditional approaches attempt to shield proteins from degradation in the stomach. Our platform bypasses this limitation entirely by generating therapeutic proteins directly within the gastrointestinal environment.

Patent-pending platform capable of delivering

enzymes, peptides, and antibodies.

Step 1: Oral Administration

Engineered bacteriophage are delivered orally.

Step 2: Targeted Infection

Phage selectively infect resident gut bacteria.

Step 3: In Situ Production

Infected bacteria produce therapeutic proteins.

Step 4: Localized Delivery

Therapeutics are delivered directly within the gastrointestinal tract.